Allen Moseley is the Managing General Partner at Noro-Moseley Partners. See sector focus and contact routes.
Allen Moseley is the Managing General Partner at Noro-Moseley Partners, having joined the Atlanta-based venture capital firm in 1998 and leading its healthcare practice. He focuses primarily on healthcare information technology and healthcare services within the firm’s broader thesis of investing in early growth equity B2B software and healthcare companies across the United States and Canada. The firm typically invests $2 million to $7 million in early-stage companies and up to $10 million in growth companies, with follow-on capabilities of up to $20 million per transaction. Moseley serves as Chairman of the Board at Medix Infusion and holds board positions at Elligo Health Research, Upward Health, Cariloop, and Pure Life Renal, reflecting deep operational involvement in his portfolio. His portfolio also includes companies such as Rialtic, where he acts as a Board Observer, and Medix Infusion, a notable healthcare infusion services company. Moseley holds an MBA from Harvard Business School and a BA from the University of North Carolina at Chapel Hill, and he chairs the Advisory Board for UNC’s Institute for the Arts and Humanities. While no public writing
Every field above is read from the StartupFundraising investor directory — disclosed location, recorded investments and stated focus — and re-checked as filings arrive. Founders pair it with investors in Atlanta when building a target list.
Investors like Allen Moseley · Full investor directory · Investor access · Company funding database